Search clinical trials for: HPV-

Total 1403 results

University of Rochester
Centers for Disease Control and Prevention

Completed

Optimizing Application And Support Of Immunization Information Systems (OASIS) (OASIS)

Increase in Use of Immunization Registry | Increase in HPV Vaccination Rate

United States
VCS Foundation
Cancer Council New South Wales

Active, not recruiting

Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia (Compass)

Cervical Intraepithelial Neoplasia | Cancer of the Cervix

Australia
N.N. Petrov National Medical Research Center of...

Recruiting

Clinical Validation of Cervical Cancer Screening Methods

Cervical Cancer | Human Papilloma Virus | Cervical Dysplasia

Russian Federation
Fox Chase Cancer Center
Temple University

Recruiting

Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening

Uterine Cervical Neoplasms

United States
University of Washington
National Cancer Institute (NCI); University of California, Davis; University... and other collaborators

Completed

Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women

Cervical Cancer

United States
Shanghai Bovax Biotechnology Co., Ltd.
Chongqing Bovax Biopharmaceutical Co., Ltd.

Recruiting

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Cervical Cancer | Vulvar Cancer | Vaginal Cancer | CIN1 | CIN2 | VaIN1 | VaIN2 | VaIN3 | Genital Wart | VIN 1 | VIN 2 | VIN 3 | AIS | HPV Infections | CIN 3

China
GlaxoSmithKline

Completed

Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.

Infections, Papillomavirus

Taiwan, Spain, Germany, Colombia, France, Sweden, Australia, Korea, Republic of, Honduras, Czech Republic, Norway, Panama
GlaxoSmithKline

Completed

Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18

Infections, Papillomavirus

Finland, Russian Federation, Denmark, Greece, Netherlands, Estonia
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Not yet recruiting

Treatments of HPV-related Lesions

Cervical Cancer | HPV | Cervix Lesion | Vagina Disease
Procare Health Iberia S.L.
Adknoma Health Research

Active, not recruiting

Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions. (PALOMA2)

Human Papilloma Virus Infection | Human Papilloma Virus | Cervix Lesion

Spain
Genexine, Inc.

Completed

Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers

Human Papillomavirus

Korea, Republic of
Ohio State University Comprehensive Cancer Center

Completed

HPV Self-Test Intervention in Ohio Appalachia

Cervical Carcinoma | Human Papillomavirus Infection

United States
Centre Hospitalier Universitaire de Besancon

Terminated

Evaluation of Viral Status of Patients With Plantar Warts Included in VRAIE Study, Non-responder to Study Treatment (BIOVRAIE)

Plantar Warts
National Taiwan University Hospital

Unknown

e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma Viruses

Cervical Cancer | Human Papilloma Virus Infection

Taiwan
Cynthia S Firnhaber
Merck Sharp & Dohme LLC

Completed

A Study to Examine the Human Papillomavirus Types Exposure in Women From Southern Africa and Brasil

HIV Infections | HIV

Botswana, Brazil, South Africa
McGill University

Active, not recruiting

Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study (TRAP-HPV)

Human Papillomavirus Infection

Canada
GlaxoSmithKline

Completed

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US

Infections, Papillomavirus

United States, Canada
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age

Infections, Papillomavirus

Romania, Italy, Slovakia
GlaxoSmithKline

Completed

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand

Infections, Papillomavirus

Taiwan, Thailand, Brazil
Sinocelltech Ltd.
Sichuan Center for Disease Control and Prevention; Guangxi Center for Disease... and other collaborators

Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years

HPV-Related Carcinoma | HPV InfectioN

China
Chulalongkorn University

Unknown

The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease, Stage V

Thailand
University of Chicago

Recruiting

Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer

HPV-Negative Squamous Cell Carcinoma

United States
London School of Hygiene and Tropical Medicine
Merck Sharp & Dohme LLC; Public Health England; University of Cambridge

Active, not recruiting

HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine Trial (HPV)

Human Papillomavirus Vaccine

Gambia
University of Rochester

Completed

Text Reminders to Immunize in a Managed Care Organization (TRIO)

Human Papilloma Virus

United States
University of Washington

Active, not recruiting

Immunogenicity of Fractional Dose of the HPV Vaccines

HPV Infection | HPV Vaccine

United States
Hospital San Carlos, Madrid
Merck Sharp & Dohme LLC

Unknown

Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN. (VENUS)

HPV Infection | HPV Vaccine | Cervix Lesion | Cervix, Dysplasia

Spain
GlaxoSmithKline

Completed

Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years

Infections, Papillomavirus

Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Recruiting

Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts (VAC-WARTS)

Palmar or Plantar Warts

France
University of Arkansas

Completed

A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions

Cervical Intraepithelial Neoplasia

United States
Shanghai Bovax Biotechnology Co., Ltd.
Chongqing Bovax Biopharmaceutical Co., Ltd.

Completed

Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Cervical Cancer | Vulvar Cancer | Vaginal Cancer | CIN1 | CIN2 | CIN3 | VaIN1 | VaIN2 | VaIN3 | Genital Wart | VIN 1 | VIN 2 | VIN 3 | AIS

China
University of Maryland, Baltimore
National Institute of Dental and Craniofacial Research (NIDCR)

Completed

0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of the Head and Neck

United States
University of Sao Paulo

Completed

Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil (HPV)

Infection

Brazil
Kenya Medical Research Institute
Merck Sharp & Dohme LLC; University of Washington

Completed

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

HPV Infection | HPV Vaccine | HIV-1-infection

Kenya
Inovio Pharmaceuticals

Completed

INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)

Respiratory Papillomatosis

United States
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins University; Dana-Farber Cancer Institute; Icahn School of Medicine... and other collaborators

Completed

Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time (HOTSPOT)

Oropharyngeal Cancer | Human Papillomavirus

United States
Duke University

Completed

SDH of HPV Vaccine Completion

Human Papilloma Virus

United States
Milton S. Hershey Medical Center

Terminated

Self-sampling for Human Papillomavirus (HPV) Among Patients Receiving Colposcopy

HPV

United States
Medical University of Vienna

Completed

Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment

HPV

Austria
Charles University, Czech Republic

Not yet recruiting

The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization

Recurrence | Cervical Intraepithelial Neoplasia Grade 2/3

Czechia
Institut de Cancérologie de Lorraine

Completed

Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort (PAPILLOR)

Human Papillomavirus-Related Cervical Carcinoma

France
University of Aarhus
Aarhus University Hospital

Completed

Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults (HIPAVAC)

HIV | Human Papillomavirus

Denmark
Mayo Clinic
National Cancer Institute (NCI)

Completed

Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Pathologic Stage I HPV-Mediated (p16-Positive)... and other conditions

United States
Miriam Elfström
Karolinska University Hospital

Recruiting

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Cervical Cancer | HPV Infection | CIN 2/3

Sweden
Boston Medical Center
Boston University; American Cancer Society, Inc.

Completed

DOSE HPV: Development of Systems and Education to Improve HPV Vaccination Rates

Behavior
University of British Columbia
National Cancer Institute (NCI); British Columbia Cancer Agency

Active, not recruiting

Long-Term Follow-Up of HPV FOCAL Participants (HPV FOCAL)

Cervical Cancer

Canada
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.

Human Papillomavirus (HPV) Infection

Senegal, Tanzania
University of California, Los Angeles
National Cancer Institute (NCI); University of Colorado, Denver; New York State...

Completed

HPV Centralized R/R RCT #2 - New York State

Vaccines

United States
University Hospital, Geneva

Completed

Feasibility and Acceptability of Offering Self-sampling to Non-attendees in Primary Care (DEPIST)

Cancer of the Uterine Cervix
GlaxoSmithKline

Completed

Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects

Infections, Papillomavirus

United States, Australia, Finland, Germany, Taiwan, Belgium, Spain, Canada, Thailand, Italy, United Kingdom, Brazil, Philippines
The University of Texas Medical Branch, Galveston
Cancer Prevention Research Institute of Texas

Active, not recruiting

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

Efficacy | Human Papilloma Virus | Immunization

United States

Search clinical trials for: HPV-

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations